Breaking News, Promotions & Moves

CordenPharma Names New CEO

ICIG appoints Michael Quirmback to lead its CDMO platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

CordenPharma Group, the global pharmaceutical service and manufacturing platform of International Chemical Investors Group (ICIG), has appointed Michael Quirmbach as chief executive officer and president, effective August 1, 2019. Dr. Quirmbach joined CordenPharma in October 2014 as chief business officer and has been a member of the executive leadership team. Since then he has been instrumental in establishing CordenPharma in the market as a contract development and manufacturing organization (...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters